Evidence map›Paper›PMID 34236082›Full record

ReviewJournal of food biochemistry2021

Therapeutic potential of phytoconstituents of edible fruits in combating emerging viral infections.

Veerasamy Pushparaj Santhi, Poomaruthai Masilamani, Venkatraman Sriramavaratharajan, Ramar Murugan, Shailendra S Gurav, Veerasamy Pushparaj Sarasu, Subbaiyan Parthiban, Muniappan Ayyanar

Open access · greenAbstract readReview
In one paragraph

Review in Journal of food biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Potency of Xanthone Derivatives fromMolecules (Basel, Switzerland) · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Paving New Roads Towards Biodiversity-Based Drug Development in Brazil: Lessons from the Past and Future Perspectives.Revista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia · 2021
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Veerasamy Pushparaj SanthiDepartment of Fruit Science, Horticultural College and Research Institute for Women, Tamil Nadu Agricultural University, Tiruchirappalli, India.
Poomaruthai MasilamaniDepartment of Fruit Science, Horticultural College and Research Institute for Women, Tamil Nadu Agricultural University, Tiruchirappalli, India.
Venkatraman SriramavaratharajanVirchow Biotech Private Limited, Hyderabad, India.
Ramar MuruganCentre for Research and Postgraduate Studies in Botany, Ayya Nadar Janaki Ammal College (Autonomous), Sivakasi, India.
Shailendra S GuravDepartment of Pharmacognosy and Phytochemistry, Goa College of Pharmacy, Goa University, Panaji, India.
Veerasamy Pushparaj SarasuDepartment of Clinical Microbiology, Government Medical College, Pudukkottai, India.
Subbaiyan ParthibanDepartment of Fruit Science, Horticultural College and Research Institute for Women, Tamil Nadu Agricultural University, Tiruchirappalli, India.
Muniappan AyyanarDepartment of Botany, A.V.V.M. Sri Pushpam College (Autonomous), Bharathidasan University, Thanjavur, India.ORCID https://orcid.org/0000-0003-4685-6376
Tamil Nadu Agricultural University · INBharathidasan University · INBotanical Survey of India · INGoa University · INGovernment Medical College · INVirchow BioTech (India) · IN

Funding

Science and Engineering Research Board EMR/2016/007164
6 · The paper itself

Abstract

Plant-derived bioactive molecules display potential antiviral activity against various viral targets including mode of viral entry and its replication in host cells. Considering the challenges and search for antiviral agents, this review provides substantiated data on chemical constituents of edible fruits with promising antiviral activity. The bioactive constituents like naringenin, mangiferin, α-mangostin, geraniin, punicalagin, and lectins of edible fruits exhibit antiviral effect by inhibiting viral replication against IFV, DENV, polio, CHIKV, Zika, HIV, HSV, HBV, HCV, and SARS-CoV. The significance of edible fruit phytochemicals to block the virulence of various deadly viruses through their inhibitory action against the entry and replication of viral genetic makeup and proteins are discussed. In view of the antiviral property of active constituents of edible fruits which can strengthen the immune system and reduce oxidative stress, they are suggested to be diet supplements to combat various viral diseases including COVID-19. PRACTICAL APPLICATIONS: Considering the increasing threat of COVID-19, it is suggested to examine the therapeutic efficacy of existing antiviral molecules of edible fruits which may provide prophylactic and adjuvant therapy with their potential antioxidant, anti-inflammatory, and immune-modulatory effects. Several active molecules like geraniin, naringenin, (2R,4R)-1,2,4-trihydroxyheptadec-16-one, betacyanins, mangiferin, punicalagin, isomangiferin, procyanidin B2, quercetin, marmelide, jacalin lectin, banana lectin, and α-mangostin isolated from various edible fruits have showed promising antiviral properties against different pathogenic viruses. Especially flavonoid compounds extracted from edible fruits possess potential antiviral activity against a wide array of viruses like HIV-1, HSV-1 and 2, HCV, INF, dengue, yellow fever, NSV, and Zika virus infection. Hence taking such fruits or edible fruits and their constituents/compounds as dietary supplements could deliver adequate plasma levels in the body to optimize the cell and tissue levels and could lead to possible benefits for the preventive measures for this pandemic COVID-19 situation.

Indexed as

COVID-19immune-modulatorsphytochemicalstherapeuticsviral replication

Identifiers

PMID34236082
PMCPMC8420441
OpenAlexW3181841024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.